Dr. Arun Kumar Nagabandi, MD

Dr. Nagabandi practices at Carolina Heart Specialists in Lancaster, South Carolina.

Dr. Nagabandi's NPI, 1265797534, was assigned on July 11, 2012. Dr. Nagabandi holds South Carolina license 91387.

Dr. Nagabandi's primary practice is Carolina Heart Specialists, at 1029 W Meeting St, Lancaster, SC 29720 in Lancaster County. The practice phone is (803) 285-2041.

Dr. Nagabandi's primary practice is Carolina Heart Specialists in Lancaster, South Carolina. Dr. Nagabandi is also affiliated with MUSC Health Lancaster Medical Center. The medical group on file is Carolina Heart Specialists. Dmand AI also links Dr. Nagabandi to 5 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagabandi practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nagabandi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Nagabandi's licenses on file in 4 states: South Carolina, Florida, Kentucky and North Carolina.

CMS data shows 1,582 Medicare services from Dr. Nagabandi across 16 procedure codes in 2024, for 516 Medicare patients. Medicare paid $94,922 for them.

CMS counts 516 Medicare patients who saw Dr. Nagabandi in 2024. The largest group is 75 to 84, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagabandi's median patient age at 69, with 51% women.

In 2024, Dr. Nagabandi wrote 608 Medicare Part D claims for 180 patients. 82% of them were for generic drugs. CMS names the drug for 500 of them, across 18 drugs with 11 or more claims each, at $62,002 in total drug cost. In 2023, CMS named 1,659 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Nagabandi for performance year 2024, reported as part of a group. Dr. Nagabandi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nagabandi as offering telehealth. CMS counts 23 procedures of coronary angioplasty and stenting by Dr. Nagabandi, more than 55% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Nagabandi, published from 2015 to 2021. 2019 was the busiest year, with 5. The most frequent topics are Atherectomy, Coronary, Coronary Artery Disease and Percutaneous Coronary Intervention. Dr. Nagabandi has published most often in Cardiovasc Revasc Med. Dr. Nagabandi's most frequent co-authors are Nirat Beohar, MD, Deepak Kapoor, MD and Hemang Bhadreshkumar Panchal, MD.

CMS Open Payments shows 427 general payments to Dr. Nagabandi from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Medtronic, Inc. paid the most, $4,027.